KRT19 and non-small cell lung carcinoma: Elevated levels of the Cytokeratin-19 fragment (CYFRA 21-1) have been identified in patients with non-small cell lung cancer (NSCLC), suggesting its potential role as a diagnostic or prognostic marker (Pujol et al., 1996).